http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2164638-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4acae202b6a15394281949545e70d2f6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate | 1995-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f1c8ab5f5a3dc1d2117a7a722b92d61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b04c908d0b908abb49dbf3ca0d435a51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_228633e000b44075aa289781cc5fc2db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_019039578c94a0e8710e2b7bcaac186f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5a5a08c0d412dffdba7ebaaa8bfefc1 |
| publicationDate | 2003-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2164638-C |
| titleOfInvention | Novel erythromycin derivatives, method for preparing same and use thereof as drugs |
| abstract | The subject of the invention is the compounds of general formula (I), in which: or R1 and R2, which are identical or different, represent a hydrogen atom, or a hydrocarbon radical containing up to 24 carbon atoms, saturated or unsaturated, possibly interrupted by one or more heteroatoms and possibly bearing one or more functional groups; or else R1 and R2 form with the nitrogen atom to which they are attached a heterocycle containing optionally one or more heteroatoms selected from nitrogen, oxygen and sulfur; or else R1 and R2 together a radical (a) in which R'1 and R'2 identical or different represent a hydrogen atom or a radical hydrocarbon containing up to 23 carbon atoms, saturated or unsaturated, possibly interrupted by one or more heteroatoms and optionally one or more functional groups and Z represents a hydrogen atom or the remainder of a carboxylic acid containing up to 18 carbon atoms, as well as the addition salts with the acids of the compounds of formula (I). The compounds of formula (I) have interressants antibiotic properties. |
| priorityDate | 1994-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 192.